Cardiometabolic risk refers to an individual’s chances of developing type 2 diabetes and cardiovascular disease (CVD) due to the presence of “traditional” risk factors and emerging markers. These risk factors include age, gender, blood pressure (BP), diabetes (hyperglycemia), smoking, LDL cholesterol, HDL cholesterol, and features of the metabolic syndrome. These features are most often found in individuals with overweight/obesity (particularly abdominal obesity), insulin resistance, atherogenic dyslipidemia, and a pro-thrombotic, inflammatory state. As an indicator of global CVD risk, cardiometabolic risk includes traditional risk factors while taking into account the potential contribution of intra-abdominal (visceral) obesity and/or insulin resistance and related metabolic markers

  • Track 1-1 Impact of genetics
  • Track 2-2 Disturbed levels of renin–angiotensin–aldosterone system and their effects

Related Conference of Cardiology